196 related articles for article (PubMed ID: 12058150)
1. Tazarotene (tazorac) for acne.
Med Lett Drugs Ther; 2002 Jun; 44(1132):52-3. PubMed ID: 12058150
[No Abstract] [Full Text] [Related]
2. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Kakita L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
[TBL] [Abstract][Full Text] [Related]
3. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
Leyden J; Lowe N; Kakita L; Draelos Z
Cutis; 2001 Jun; 67(6 Suppl):10-6. PubMed ID: 11499327
[TBL] [Abstract][Full Text] [Related]
4. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
5. Topical retinoids in the management of acne: the best path to clear results.
Del Rosso JQ
Cutis; 2004 Oct; 74(4 Suppl):2-3. PubMed ID: 15543712
[No Abstract] [Full Text] [Related]
6. Tazarotene foam, 0.1%, for the treatment of acne.
Smith JA; Narahari S; Hill D; Feldman SR
Expert Opin Drug Saf; 2016 Jan; 15(1):99-103. PubMed ID: 26560170
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and treatment of acne.
Bogal CB
Adv Nurse Pract; 2010 Apr; 18(4):22. PubMed ID: 20486299
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of topical tazarotene: a review.
Talpur R; Cox K; Duvic M
Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):195-210. PubMed ID: 20213916
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P; Callender V
Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
[TBL] [Abstract][Full Text] [Related]
10. Developments in topical retinoid therapy for acne.
Bershad S
Semin Cutan Med Surg; 2001 Sep; 20(3):154-61. PubMed ID: 11594670
[TBL] [Abstract][Full Text] [Related]
11. A status report on topical tazarotene in the management of acne vulgaris.
Del Rosso JQ; Tanghetti E
J Drugs Dermatol; 2013 Mar; 12(3):s53-8. PubMed ID: 23545935
[TBL] [Abstract][Full Text] [Related]
12. Veltin gel (clindamycin phosphate 1.2% and tretinoin 0.025%).
Abramovits W; Oquendo M; Gupta AK
Skinmed; 2011; 9(1):49-51. PubMed ID: 21409962
[No Abstract] [Full Text] [Related]
13. Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris.
Kircik LH
J Drugs Dermatol; 2009 Jul; 8(7):650-4. PubMed ID: 19588641
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris.
Nigam PK; Anant S
Indian J Dermatol Venereol Leprol; 2005; 71(5):360-1. PubMed ID: 16394466
[No Abstract] [Full Text] [Related]
16. Acne successfully treated with acitretin in a patient with peanut allergy.
Laing ME; Murphy GM; Buckley CC
Br J Dermatol; 2008 Jul; 159(1):250-1. PubMed ID: 18489602
[No Abstract] [Full Text] [Related]
17. The only topical retinoid without a generic alternative: tazarotene.
Kircik LH
J Drugs Dermatol; 2013 Mar; 12(3):s52. PubMed ID: 23545934
[No Abstract] [Full Text] [Related]
18. ARAZLO (Tazarotene 0.045%) Lotion for Topical Treatment of Acne Vulgaris.
Gupta AK; Bruce A; Abramovits W
Skinmed; 2020; 18(2):102-105. PubMed ID: 32501793
[No Abstract] [Full Text] [Related]
19. New drug information. Acanya.
JAAPA; 2009 Apr; 22(4):12. PubMed ID: 19452815
[No Abstract] [Full Text] [Related]
20. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
Rigopoulos D; Gregoriou S; Katsambas A
Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
